NZ554183A - Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition - Google Patents
Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said compositionInfo
- Publication number
- NZ554183A NZ554183A NZ554183A NZ55418305A NZ554183A NZ 554183 A NZ554183 A NZ 554183A NZ 554183 A NZ554183 A NZ 554183A NZ 55418305 A NZ55418305 A NZ 55418305A NZ 554183 A NZ554183 A NZ 554183A
- Authority
- NZ
- New Zealand
- Prior art keywords
- liposomes
- composition according
- active ingredient
- aqueous phase
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Abstract
Description
Claims (43)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04024753 | 2004-10-18 | ||
PCT/EP2005/011054 WO2006042701A1 (en) | 2004-10-18 | 2005-10-14 | Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ554183A true NZ554183A (en) | 2009-04-30 |
Family
ID=35703778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ554183A NZ554183A (en) | 2004-10-18 | 2005-10-14 | Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition |
Country Status (17)
Country | Link |
---|---|
US (1) | US8524274B2 (en) |
EP (1) | EP1802277B1 (en) |
JP (1) | JP5688199B2 (en) |
KR (1) | KR101289917B1 (en) |
CN (1) | CN101043874A (en) |
AT (1) | ATE454884T1 (en) |
AU (1) | AU2005296719B2 (en) |
CA (1) | CA2583332C (en) |
DE (1) | DE502005008880D1 (en) |
DK (1) | DK1802277T3 (en) |
EA (1) | EA011391B1 (en) |
ES (1) | ES2339577T3 (en) |
NZ (1) | NZ554183A (en) |
PL (1) | PL1802277T3 (en) |
PT (1) | PT1802277E (en) |
SI (1) | SI1802277T1 (en) |
WO (1) | WO2006042701A1 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
CN101269212B (en) * | 2008-04-30 | 2013-09-18 | 上海麟翔生物技术有限公司 | Gargle capable of being swallowed |
DE102009031274A1 (en) * | 2009-06-30 | 2011-01-13 | Justus-Liebig-Universität Giessen | Liposomes for pulmonary application |
WO2011085361A1 (en) * | 2010-01-11 | 2011-07-14 | Inotek Pharmaceuticals Corporation | Combination, kit and method of reducing intraocular pressure |
CN102970965A (en) * | 2010-04-05 | 2013-03-13 | Sk化学公司 | Composition containing PDE5 inhibitor for relieving skin wrinkles |
CO6280050A1 (en) * | 2010-06-08 | 2011-05-20 | Sante S A Lab | PHARMACEUTICAL FORM OF PHOSPHODESTERASE INHIBITORS FOR TRANSMUCOUS ADMINISTRATION |
RU2482847C2 (en) * | 2010-11-17 | 2013-05-27 | Леонид Леонидович Клопотенко | Pharmaceutical composition, containing sildenafil or alprostadil, minoxidil or euphyllin, testosteron or yohimbine and liposomes for local application |
US10016389B2 (en) * | 2011-01-05 | 2018-07-10 | Livon Laboratories | Method of making liposomes, liposome compositions made by the methods, and methods of using the same |
WO2012125214A1 (en) * | 2011-03-17 | 2012-09-20 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
EP2797599B9 (en) * | 2011-12-26 | 2019-01-23 | Tritech Biopharmaceuticals Co. Ltd. | Method and improved pharmaceutical composition for enhancing transdermal delivery of pde-5 inhibitor |
US9445993B2 (en) * | 2012-04-16 | 2016-09-20 | Rutgers, The State University Of New Jersey | Nanotechnology approach for inhalation therapies |
US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
US8871260B2 (en) * | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
US8871258B2 (en) * | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
CN106456722B (en) * | 2014-03-20 | 2021-04-02 | 泰克年研究发展基金会公司 | Delivery system comprising proteolytic enzymes or effectors thereof for use in a method for oral treatment and uses thereof |
CA2983358C (en) | 2015-03-16 | 2023-10-31 | Mireca Medicines Gmbh | Targeted liposomal delivery of cgmp analogues |
US20190110988A1 (en) * | 2017-10-17 | 2019-04-18 | Lemulsa Technologies Inc. | Delivery System That Utilizes Liposomal or Emulsion Vehicles |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2026340B (en) * | 1978-07-03 | 1982-12-22 | Ash P | Stabilising microvesicles |
MX9203808A (en) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS. |
US4937078A (en) | 1988-08-26 | 1990-06-26 | Mezei Associates Limited | Liposomal local anesthetic and analgesic products |
IL91664A (en) | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
FR2716110B1 (en) * | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Cosmetic or pharmaceutical compositions comprising liposomes. |
AU690377B2 (en) | 1994-11-04 | 1998-04-23 | Polymun Scientific Immunobiologische Forschung Gmbh | Application of superoxide dismutase in liposomes |
US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
US20040014761A1 (en) | 1997-10-28 | 2004-01-22 | Place Virgil A. | Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
CA2305394C (en) * | 1997-10-28 | 2006-12-12 | Vivus, Incorporated | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
RU2130771C1 (en) * | 1998-06-01 | 1999-05-27 | Автушенко Сергей Сергеевич | Method of preparing liposomal preparations |
GB9813100D0 (en) * | 1998-06-18 | 1998-08-19 | Secr Defence | Method of forming liposomes |
TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
IT1312310B1 (en) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | USE OF SELECTIVE 1B ADRENERGIC RECEPTOR ANTAGONISTS TO IMPROVE SEXUAL DYSFUNCTION |
US6762202B2 (en) * | 2000-05-09 | 2004-07-13 | Nitromed, Inc. | Infrared thermography and methods of use |
US7223406B2 (en) * | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
EP1203614A1 (en) | 2000-11-03 | 2002-05-08 | Polymun Scientific Immunbiologische Forschung GmbH | Process and apparatus for preparing lipid vesicles |
US20060165766A1 (en) | 2001-09-06 | 2006-07-27 | Yechezkel Barenholz | Method for preparing liposome formulations with a predefined release profile |
US6833139B1 (en) * | 2002-01-09 | 2004-12-21 | Ferndale Laboratories, Inc. | Composition and method for the treatment of anorectal disorders |
EP1519714B1 (en) * | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
CN101229127B (en) * | 2002-11-26 | 2012-10-10 | 吉里德科学公司 | Liposome preparation |
-
2005
- 2005-10-14 EP EP05802312A patent/EP1802277B1/en active Active
- 2005-10-14 CA CA2583332A patent/CA2583332C/en active Active
- 2005-10-14 ES ES05802312T patent/ES2339577T3/en active Active
- 2005-10-14 WO PCT/EP2005/011054 patent/WO2006042701A1/en active Application Filing
- 2005-10-14 CN CNA2005800356693A patent/CN101043874A/en active Pending
- 2005-10-14 PT PT05802312T patent/PT1802277E/en unknown
- 2005-10-14 DE DE502005008880T patent/DE502005008880D1/en active Active
- 2005-10-14 EA EA200700892A patent/EA011391B1/en not_active IP Right Cessation
- 2005-10-14 AU AU2005296719A patent/AU2005296719B2/en not_active Ceased
- 2005-10-14 SI SI200530965T patent/SI1802277T1/en unknown
- 2005-10-14 DK DK05802312.8T patent/DK1802277T3/en active
- 2005-10-14 KR KR1020077008391A patent/KR101289917B1/en active IP Right Grant
- 2005-10-14 AT AT05802312T patent/ATE454884T1/en active
- 2005-10-14 JP JP2007536100A patent/JP5688199B2/en not_active Expired - Fee Related
- 2005-10-14 PL PL05802312T patent/PL1802277T3/en unknown
- 2005-10-14 NZ NZ554183A patent/NZ554183A/en not_active IP Right Cessation
- 2005-10-14 US US11/577,488 patent/US8524274B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20070069164A (en) | 2007-07-02 |
DE502005008880D1 (en) | 2010-03-04 |
WO2006042701A1 (en) | 2006-04-27 |
AU2005296719A1 (en) | 2006-04-27 |
EA011391B1 (en) | 2009-02-27 |
PL1802277T3 (en) | 2010-07-30 |
JP5688199B2 (en) | 2015-03-25 |
ES2339577T3 (en) | 2010-05-21 |
EP1802277B1 (en) | 2010-01-13 |
US20090324698A1 (en) | 2009-12-31 |
EP1802277A1 (en) | 2007-07-04 |
CA2583332A1 (en) | 2006-04-27 |
PT1802277E (en) | 2010-04-01 |
AU2005296719B2 (en) | 2011-02-03 |
CA2583332C (en) | 2013-10-01 |
SI1802277T1 (en) | 2010-05-31 |
EA200700892A1 (en) | 2007-08-31 |
DK1802277T3 (en) | 2010-05-17 |
US8524274B2 (en) | 2013-09-03 |
KR101289917B1 (en) | 2013-07-25 |
CN101043874A (en) | 2007-09-26 |
ATE454884T1 (en) | 2010-01-15 |
JP2008516911A (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2583332C (en) | Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition | |
Elsayed et al. | Lipid vesicles for skin delivery of drugs: reviewing three decades of research | |
US20090105336A1 (en) | Beneficial Effects of Increasing Local Blood Flow | |
US20090123528A1 (en) | Transdermal delivery of beneficial substances effected by a hostile biophysical environment | |
US20110028548A1 (en) | Beneficial effects of increasing local blood flow | |
JP2007533666A (en) | Cholinesterase inhibitors in liposomes and their preparation and use | |
Jothy et al. | An overview on niosome as carrier in dermal drug delivery | |
US9226909B2 (en) | Beneficial effects of increasing local blood flow | |
US20230414511A1 (en) | Compositions and methods for deep dermal drug delivery | |
WO2002102385A1 (en) | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis | |
JP2014522848A (en) | Topical formulation containing lipid microcapsule delivery vehicle and use thereof | |
CN116710067A (en) | Compositions and methods for deep skin drug delivery | |
IT201900006595A1 (en) | Formulation for the enhancement of sexual performance | |
MXPA06012120A (en) | Cholinesterase inhibitors in liposomes and their production and use. | |
IT202100018602A1 (en) | GSH-C4 compound for use in the treatment of psoriasis | |
Vani et al. | ETHOSOMES: A NOVEL TOOL FOR TRANSDERMAL DRUG DELIVERY | |
KR19980074807A (en) | Formulation of pharmaceutical composition for treating erectile dysfunction | |
KR20010016165A (en) | The topical therapeutic preparations for sexual dysfunctions of men and women | |
MXPA00011386A (en) | A medicament for prevention and treatment of sexual dysfunction | |
EP2380579A1 (en) | Beneficial effects of increasing local blood flow |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2016 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20150930 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2017 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20160920 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2018 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20170927 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2019 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20180930 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2020 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20190927 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2021 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20200919 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2022 BY EUROPEAN PATENT ANNUITY SERVICE GMBH Effective date: 20211002 |
|
LAPS | Patent lapsed |